Comparative Study of Hepatitis B Pts:The BE-LOW Study

ID Number 07-0557

Principal Investigator(s)
Douglas Dieterich

Department(s) or Division(s)
Liver Diseases

Description

The purpose of this study is find out how safe and effective the combination of entecavir (a nucleoside analog) plus tenofovir (a nucleotide analog) is compared to entecavir alone for the treatment of hepatitis B infection.



Contact Information
Douglas Dieterich, MD
douglas.dieterich@mountsinai.org

Recruiting Patients: No